Diabetes: metformin and SGLT2 inhibitors (early onset T2DM)

  • In development GID-IND10349
  • Expected publication date: TBC

Register as a stakeholder

Status:
In progress
Process:
IND

Timeline

Key events during the development of the guidance:

DateUpdate
08 April 2026 - 06 May 2026NICE indicator consultation
08 April 2026Statement